Contineum Therapeutics (CTNM) Stock Price & Financial Analysis
Contineum Therapeutics Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Contineum Therapeutics
What is the current stock price for CTNM?
As of the latest trading session, CTNM stock trades at $13.36. The 52-week range is $3.72–$16.33, with a day range of $12.78–$13.65.
What is the P/E ratio for CTNM?
The P/E ratio (Price-to-Earnings) for CTNM is shown in the Key Statistics section. This valuation metric helps compare Contineum Therapeutics, Inc. to industry peers.
Does CTNM pay dividends?
Contineum Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for CTNM?
Based on 5 analysts, the consensus for CTNM is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.
What is the market cap of CTNM?
Contineum Therapeutics's market capitalization is $498.8M, classifying it as a small-cap company. Contineum Therapeutics operates in the Healthcare sector within the Biotechnology industry.